On Wednesday, 30th June, Bed Bath & Beyond (NASDAQ BBBY) published the quarterly earnings results. An EPS of $0.05 was reported, which failed to reach the consensus $0.08 estimate by Thomson Reuters.
Stock Overview Of BBBY
Apart from the EPS, a negative 1.63% net margin as well as a negative 8.44% equity return was reported for BBBY. The quarterly revenue reported stood at $1.95Bn, topping the consensus $1.87Bn estimate by analysts. In the same period last year, an $1.96 EPS was reported. The quarterly revenue of the firm had increased by 49.5% on a YOY basis. The Q2 EPS guidance was updated to be between $0.48 and $0.55. Its guidance for FY22 EPS was updated to be between $1.40 and $1.55.
On Wednesday, the stocks of BBBY had an opening value of $30.61. The moving average over a period of 50 days currently stands at $27.81. The highest and lowest value of the stock over a period of one year currently stands at $53.90 and $7.39 respectively. The debt/equity, current, and quick ratios of the company currently stand at 0.93, 1.58, and 0.85 respectively. The market capitalization currently stands at $3.26Bn with a -24.52 P/E ratio and a 1.83 beta.
Several research analysts have issued their reports on BBBY stocks. KeyCorp reissued a rating of “sell” while issuing a price target of $22 on 11th June, Friday. Loop Capital decreased its target price to $24 from $30 while issuing a rating of “hold” on 16th April, Friday. Telsey Advisory Group decreased their target price to $30 from $40 while issuing a rating of “market perform” on 15th April, Thursday. Wedbush decreased their target price to $27 from $33 while issuing a rating of “neutral” on 15th April, Thursday. JPMorgan Chase & Co. increased their target price to $29 from $23 while issuing a rating of “neutral” on 19th April, Monday.
